Compare Agilysys Inc (AGYS) vs Neurocrine Biosciences Inc (NBIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Agilysys Inc vs Neurocrine Biosciences Inc — how do they compare? Agilysys Inc trades at $106.05 (market cap $3.00B), while Neurocrine Biosciences Inc trades at $152.5 (market cap $16.46B). The key difference: Neurocrine Biosciences Inc is far larger — about 5.5× Agilysys Inc's market cap. Which is the better fit depends on your goals.
| AGYS | NBIX | |
|---|---|---|
Market Cap | $3.00B | $16.46B |
Sector | Technology | Health |
52-Week High | $141.12 | $185.50 |
52-Week Low | $62.19 | $123.10 |
Enterprise Value | $2.90B | $16.48B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Agilysys Inc
Agilysys provides enterprise software and SaaS solutions for the hospitality industry. Its products specialize in point-of-sale, property management, and inventory systems for hotels, resorts, and cruise lines.
Read more on AGYS →About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →
